Product reference notes for rapid antigen tests to diagnose SARS-CoV-2

Rapid antigen tests for detection of SARS-CoV-2 infection are added to UNICEF Supply Catalogue.

About

Rapid antigen tests for COVID-19 diagnosis have been added to the UNICEF diagnostics portfolio and are now available for UNICEF programme countries and procurement services partners in addition to manual and automated real-time PCR tests. Like all other COVID-19 diagnostics procured by Supply Division, rapid antigen tests are quality-assured, i.e. either listed under the WHO Emergency Use List (EUL) or holding the FDA Emergency Use Authorization (EUA).

Rapid antigen tests for COVID-19 diagnosis are available with very short FCA lead times, which is critical for countries struggling with COVID-19 supply shortages and interruptions. More rapid antigen tests will be added as they become available.

Product reference notes for all COVID-19 diagnostics are available and useful for evaluators and decision-makers. The notes include comprehensive technical and commercial information, such as kit contents, storage conditions, as well as price and indicative lead time.

Download document

(PDF, 172,82 KB) (PDF, 73,55 KB) (PDF, 54,76 KB)